104
A. Rivera et al. / Tetrahedron Letters 51 (2010) 102–104
4. Rivera, A.; Maldonado, M.; Núñez, M. E.; Joseph-Nathan, P. Heterocycl. Commun.
2004, 10, 77–80.
zimidazol-1-yl)methyl)-1H-benzotriazole (8) (Scheme 1), which
has been reported for the preparation of benzimidazole
derivatives.12,13
5. Preparation of N1,N2-bis((1H-benzotriazol-1-yl)methyl)-benzene-1,2-diamine (3):
A
mixture of 1 g (3.79 mmol) of DMDBTA and 0.9 g (7.58 mmol) of
benzotriazole in 5 mL of ethyl acetate was stirred for 12 h at room
temperature. The precipitated solid was collected by filtration and was
washed with ethyl acetate and dried in vacuo: yield 85%, mp 156–158 °C. 1H
NMR (400 MHz, DMSO-d6): d 6.17 (d, J = 6.84 Hz, 4H), 6.51 (t, J = 6.84 Hz, 2H, –
NH), 6.48 (m, 2H), 6.75 (m, 2H), 7.34 (t, J = 7.88 Hz, 2H, Bt), 7.47 (t, J = 7.88 Hz,
2H), 7.98 (d, J = 7.88 Hz, 4H).13C NMR (100 MHz, DMSO-d6) d: 57.3, 111.0,
112.5, 119.0, 119.2, 123.9, 127.1, 132.2, 133.1, 145.4.
There are two plausible reaction pathways that would explain
the selective elimination of one benzotriazolyl moiety (Btz) of 3
to produce 8. The first one (pathway A in Scheme 1) involves a
stepwise mechanism with a rate-limiting expulsion of the benzo-
triazolate leaving group to give the cationic intermediate (10),
which undergoes an intramolecular cyclization. The second pro-
posed pathway (B in Scheme 1) may be explained by the presump-
tion that the preferred conformation of the molecule acts as an
organic template which induces pre-organization to favor its sub-
sequent cyclization to the benzimidazole ring, involving a con-
certed mechanism with simultaneous bond formation and fission
in which the leaving group is expelled as an anion.
6. Katritzky, A. R.; Lan, X.; Yang, J. Z.; Denisko, O. V. Chem. Rev. 1998, 98, 409–548.
7. Crystal data for compound 3, C20H18N8, were collected using a Siemens Smart
CCD diffractometer, M = 370.42, monoclinic, P2(1)/c, a = 10.302(1),
b = 17.565(2), c = 10.662(1) Å, V = 1816.4(4) Å3, Z = 4, Dcalcd = 1.355 g/cmꢁ3, X-
ray source Mo K
a (radiation), k = 0.71073 Å, F(0 0 0) = 776, colorless prism
0.50 ꢂ 0.29 ꢂ 0.25 mm. The structure solution was obtained by direct methods
and was refined with anisotropic thermal parameters using full-matrix least
squares procedures on F2 to give R = 0.064, wR = 0.220 for 5303 independent
observed reflections and 261 parameters. Crystallographic data (excluding
structure factors) for the given structure in this Letter have been deposited
with the Cambridge Crystallographic Data Centre as supplementary
publication number CCDC 745159. Copies of these data can be obtained, free
of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax:
+44(0) 1223 336033 or email: deposit@ccdc.cam.ac.uk).
Finally, in order to investigate the reaction mechanism, we used
density functional theory (DFT) calculations to analyze the trans-
formation of 3–8. The structure of 3, the transition states, and
intermediates were further optimized using density functional the-
ory (DFT) at the B3LYP level and a 6-31G(d) basis set.14 Both tran-
sition states were characterized with vibrational frequency
analyses performed at the same theoretical level, which showed
only one imaginary frequency in each transition state.15 All the cal-
culations were carried out using the GAUSSIAN 98W program pack-
age.16 The gas-phase energy barrier at the B3LYP/6-31G* level for
the bimolecular mechanism is only 1.4 kcal/mol higher in energy
than unimolecular mechanism. However, inclusion of the solvent
effect, performed through single-point calculations on the gas-
phase optimized structures using the polarizable continuum model
(PCM),17–19 increases the free-energy barrier for the unimolecular
mechanism by 13.6 kcal molꢁ1, which indicates that the formation
of pentacoordinated transition state is thermodynamically favored.
Due to the relatively low nucleophilicity of alcohols compared
to amines and the tendency of 3 to undergo spontaneous cycliza-
tion to afford 1-((1H-benzimidazol-1-yl)methyl)-1H-benzotriazole
(8) (Scheme 1), we believe that 8 would be an obvious precursor to
6a–c. Thus, the intermediate 8, formed by oxidation, reacts by sub-
sequent nucleophilic substitution by small alcohols (Scheme 1),
whereas the observed unreactivity of the other alcohols (Table 2,
entries d–h) was expected on the basis of the mechanistic hypoth-
esis due to the lower nucleophilicity of these bulky alcohols.20 To
confirm the latter, we carried out the reactions between 8 and
the cited alcohols, but the results were similar to those previously
obtained with 3, thus we concluded that 8 was the compound
undergoing the substitution reaction. Further investigations on
the synthetic applications of N1,N2-bis((1H-benzotriazol-1-yl)-
methyl)-benzene-1,2-diamine (3) and 1-((1H-benzimidazol-1-yl)-
methyl)-1H-benzotriazole (8) are in progress.
8. Katritzky, A. R.; Steel, P. J.; Denisenko, S. N. Tetrahedron 2001, 57, 3309–3314.
9. Katritzky, A. R.; Belyakov, S. A.; Sorochinsky, A. E.; Steel, P. J.; Schall, O. F.;
Gokel, G. W. J. Org. Chem. 1996, 61, 7585–7592.
10. Katritzky, A. R.; Abdel-Fattah, A. A. A.; Tymoshenko, D. O.; Belyakov, S. A.;
Ghiviriga, I.; Steel, P. J. J. Org. Chem. 1999, 64, 6071–6075.
11. Reaction of N1,N2-bis((1H-benzotriazol-1-yl)methyl)-benzene-1,2-diamine with
alcohols: In a typical reaction, the appropriate alcohol and N1,N2-bis((1H-
benzotriazol-1-yl)methyl)-benzene-1,2-diamine were heated to reflux for
different times, ranging from 5 to 36 h. The solution was concentrated by
rotary-evaporator, and the residue was purified by column chromatography on
silica gel (eluted with benzene/ethyl acetate, 8:2) to afford: 1-(methoxymethyl)-
1H-benzimidazole (6a): 1H NMR (400 MHz, CDCl3): d 3.28 (s, 3H), 5.49 (s, 2H),
7.33 (m, 2H), 7.52 (d, J = 8 Hz, 1H), 7.81 (d, J = 8 Hz, 1H), 7.98 (s, 1H). 13C NMR
(100 MHz, CDCl3) d: 56.3, 76.0, 110.2, 120.4, 122.8, 123.6, 133.6, 143.1, 144.0
(CG–MS) m/z 162 (M+). Elemental Anal. Calcd for C9H10N2O: C, 66.6 7; H, 6.17;
N, 17.28. Found: C, 66.59; H, 6.21; N, 17.24. 1-(Ethoxymethyl)-1H-benzimidazole
(6b): 1H NMR (400 MHz, CDCl3): d 1.14 (t, J = 7 Hz, 3H), 3.43 (q, J = 7 Hz, 2H),
5.53 (s, 2H), 7.31 (t, J = 6 Hz, 2H,), 7.53 (d, J = 6.2 Hz, 1H), 7.80 (d, J = 6.5 Hz, 1H),
7.97 (s, 1H). 13C NMR (100 MHz, CDCl3) d: 14.1, 64.3, 75.5, 110.1, 120.3, 122.6,
123.4, 133.6, 143.0, 143.9 (CG–MS) m/z 176 (M+). Elemental Anal. Calcd for
C10H12N2O: C, 68.18; H, 6.82; N, 15.91. Found: C, 68.13; H, 6.86; N, 115.87. 1-
(Isopropoxymethyl)-1H-benzimidazole (6c): 1H NMR (400 MHz, CDCl3): d 1.14 (d,
J = 6.4 Hz, 6H), 3.66 (h, J = 6.4 Hz, 6H), 5.57 (s, 2H), 7.31 (t, J = 6.2 Hz, 2H), 7.54
(d, J = 6.2 Hz, 1H), 7.81 (d, J = 6.2 Hz, 1H), 7.98 (s, 1H). 13C NMR (100 MHz,
CDCl3) d: 21.9, 69.8, 72.4, 110.3, 120.4, 122.7, 123.4, 133.4, 142.8, 142.8 (CG–
MS) m/z 190 (M+). Elemental Anal. Calcd for C11H14N2O: C, 69.47; H, 7.37; N,
14.74. Found: C, 69.42; H, 7.41; N, 14.71. 1-(1H-Benzimidazol-1-yl-methyl)-1H-
1,2,3-benzotriazole (8): 1H NMR (400 MHz, CDCl3): d 6.95 (s, 2H), 7.31 (t,
J = 7.6 Hz, 1H), 7.35 (t, J = 8.1 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 7.50 (d, J = 8.1 Hz,
1H), 7.52 (t, J = 8.1 Hz, 1H), 7.70 (d, J = 7.6 Hz, 1H), 7.78 (d, J = 7.6 Hz, 2H), 8.08
(d, J = 8.1 Hz, 1H), 8.25 (s, 1H). 13C NMR (100 MHz, CDCl3) d: 55.7, 108.6, 110.0,
120.7, 120.8, 123.4, 124.3, 124.7, 128.7, 131.9, 132.9, 142.2, 143.9, 146.4 (CG–
MS) m/z 249 (M+). Elemental Anal. Calcd for C14H11N5: C, 67.47; H, 4.42; N,
28.08. Found: C, 67.41; H, 4.46; N, 28.03.
12. (a) Ivanova, N. V.; Sviridov, S. I.; Stepanov, A. E. Tetrahedron Lett. 2006, 47,
8025–8027; (b) Vojtech, M.; Petrušová, M.; Sláviková, E.; Bekešová, S.; Petruš,
L. Carbohydr. Res. 2007, 342, 119–123.
13. Gallant, A. J.; Patrick, B. O.; MacLachlan, M. J. J. Org. Chem. 2004, 69, 8739–8744.
14. Finley, J. W.; Stephens, P. J. J. Mol. Struct. (Theochem) 1995, 357, 225–235.
15. Foresman, J. B., Frish, A. E. Exploring Chemistry with Electronic Structure Methods;
Gaussian: Pittsburgh, PA, 1993.
16. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.;
Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A. Jr.; Stratmann, R. E.;
Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M.
C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.;
Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.;
Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman,
J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko,
A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-
Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.;
Johnson,B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon,
M.; Replogle, E. S.; Pople, J. A. GAUSSIAN 98, Revision A.9, Gaussian, Inc.:
Pittsburgh, PA, 1998.
In this Letter, we introduce N1,N2-bis((1H-benzotriazol-1-
yl)methyl)benzene-1,2-diamine (3) as a new starting material for
the synthesis of 1-substituted-1H-benzo[d]imidazoles. This meth-
odology represents a valid alternative to the existing procedures
especially for 1-alkylsubstituted benzimidazoles.
Acknowledgments
The authors acknowledge the Division de Investigaciones Bo-
gotá (DIB) and the Universidad Nacional de Colombia, for financial
support. M.A.N. and D.G.-S. acknowledge Colciencias for their
fellowships.
17. Tomasi, J.; Cammi, R.; Mennucci, B.; Cappeli, C.; Corni, S. Phys. Chem. Chem.
Phys. 2002, 4, 5697–5712.
18. Cossi, M.; Barone, V.; Cammi, R.; Tomasi, J. Chem. Phys. Lett. 1996, 255, 327–
335.
References and notes
19. Tomasi, J.; Mennucci, B.; Cammi, R. Chem. Rev. 2005, 105, 2999–3094.
20. (a) Luo, X. L.; Crabtree, R. H. J. Am. Chem. Soc. 1989, 111, 2527–2535; (b) Weil,
T.; Kotke, M.; Kleiner, C. M.; Schreiner, P. R. Org. Lett. 2008, 10, 1513–1516.
1. Fischer, O.; Wreszinski, H. Ber. Dtsch. Chem. Ges. 1892, 25 , 2711–2715.
2. Rivera, A.; Navarro, M. A.; Ríos-Motta, J. Heterocycles 2008, 75, 1651–1658.
3. Rivera, A.; Maldonado, M. Tetrehedron Lett. 2006, 47, 7467–7471.